This inventor holds 1 USPTO granted patent. Top assignee: Technoderma Medicines Pte Ltd.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Xiaolei Wang: Innovator in Small Molecule Compounds
Introduction
Xiaolei Wang is a notable inventor based in Zhejiang, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of small molecule compounds. His work focuses on creating innovative solutions for medical applications.
Latest Patents
Xiaolei Wang holds a patent for a small molecule compound that serves as a highly efficient and specific JAK kinase inhibitor. This compound is characterized by its ability to act as a Tyk2 inhibitor and/or a JAK1 inhibitor, and/or a JAK1/Tyk2 dual inhibitor. The patent highlights the compound's various forms, including stereoisomers, geometric isomers, and pharmaceutically acceptable salts.
Career Highlights
Wang is associated with Technoderma Medicines Pte Ltd., where he continues to advance his research and development efforts. His innovative approach to drug design has positioned him as a key player in the pharmaceutical industry.
Collaborations
Xiaolei Wang collaborates with talented individuals such as Xiang Jiang and Yuting Cai, who contribute to his research endeavors. Their combined expertise enhances the potential for groundbreaking discoveries in the field.
Conclusion
Xiaolei Wang's work in small molecule compounds exemplifies the innovative spirit of modern science. His contributions to JAK kinase inhibitors are paving the way for new therapeutic options in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile